US Stock MarketDetailed Quotes

DSGN Design Therapeutics

Watchlist
  • 5.320
  • +0.120+2.31%
Close Nov 4 16:00 ET
  • 5.320
  • 0.0000.00%
Post 16:02 ET
301.22MMarket Cap-5911P/E (TTM)

Design Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-33.43%15.04M
-33.49%14.4M
15.68%78.19M
-22.02%15.12M
-1.93%18.82M
44.48%22.6M
61.94%21.65M
88.64%67.59M
74.28%19.39M
69.29%19.19M
Selling and administrative expenses
-18.17%4.53M
-22.33%4.6M
11.31%21.13M
-20.01%4.11M
13.85%5.57M
27.35%5.53M
28.41%5.92M
71.72%18.98M
35.54%5.14M
74.70%4.89M
-General and administrative expense
-18.17%4.53M
-22.33%4.6M
11.31%21.13M
-20.01%4.11M
13.85%5.57M
27.35%5.53M
28.41%5.92M
71.72%18.98M
35.54%5.14M
74.70%4.89M
Research and development costs
-38.37%10.52M
-37.69%9.8M
17.38%57.06M
-22.75%11.01M
-7.32%13.26M
51.08%17.06M
79.59%15.73M
96.19%48.61M
94.29%14.26M
67.51%14.3M
Operating profit
33.43%-15.04M
33.49%-14.4M
-15.68%-78.19M
22.02%-15.12M
1.93%-18.82M
-44.48%-22.6M
-61.94%-21.65M
-88.64%-67.59M
-74.28%-19.39M
-69.29%-19.19M
Net non-operating interest income expense
Other net income (expense)
22.23%3.25M
39.80%3.3M
164.36%11.33M
59.80%3.28M
103.83%3.03M
315.47%2.66M
2,144.76%2.36M
1,337.92%4.29M
3,209.68%2.05M
7,731.58%1.49M
Other non- operating income (expenses)
22.23%3.25M
39.80%3.3M
164.36%11.33M
59.80%3.28M
103.83%3.03M
315.47%2.66M
2,144.76%2.36M
1,337.92%4.29M
3,209.68%2.05M
7,731.58%1.49M
Income before tax
40.85%-11.79M
42.44%-11.11M
-5.61%-66.86M
31.71%-11.84M
10.82%-15.79M
-32.92%-19.94M
-45.45%-19.29M
-78.17%-63.31M
-56.71%-17.34M
-56.42%-17.7M
Income tax
Net income
40.85%-11.79M
42.44%-11.11M
-5.61%-66.86M
31.71%-11.84M
10.82%-15.79M
-32.92%-19.94M
-45.45%-19.29M
-78.17%-63.31M
-56.71%-17.34M
-56.42%-17.7M
Net income continuous Operations
40.85%-11.79M
42.44%-11.11M
-5.61%-66.86M
31.71%-11.84M
10.82%-15.79M
-32.92%-19.94M
-45.45%-19.29M
-78.17%-63.31M
-56.71%-17.34M
-56.42%-17.7M
Minority interest income
Net income attributable to the parent company
40.85%-11.79M
42.44%-11.11M
-5.61%-66.86M
31.71%-11.84M
10.82%-15.79M
-32.92%-19.94M
-45.45%-19.29M
-78.17%-63.31M
-56.71%-17.34M
-56.42%-17.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
40.85%-11.79M
42.44%-11.11M
-5.61%-66.86M
31.71%-11.84M
10.82%-15.79M
-32.92%-19.94M
-45.45%-19.29M
-78.17%-63.31M
-56.71%-17.34M
-56.42%-17.7M
Basic earnings per share
41.67%-0.21
42.86%-0.2
-4.39%-1.19
32.26%-0.21
12.50%-0.28
-33.33%-0.36
-45.83%-0.35
-48.05%-1.14
-55.00%-0.31
-52.38%-0.32
Diluted earnings per share
41.67%-0.21
42.86%-0.2
-4.39%-1.19
32.26%-0.21
12.50%-0.28
-33.33%-0.36
-45.83%-0.35
-48.05%-1.14
-55.00%-0.31
-52.38%-0.32
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -33.43%15.04M-33.49%14.4M15.68%78.19M-22.02%15.12M-1.93%18.82M44.48%22.6M61.94%21.65M88.64%67.59M74.28%19.39M69.29%19.19M
Selling and administrative expenses -18.17%4.53M-22.33%4.6M11.31%21.13M-20.01%4.11M13.85%5.57M27.35%5.53M28.41%5.92M71.72%18.98M35.54%5.14M74.70%4.89M
-General and administrative expense -18.17%4.53M-22.33%4.6M11.31%21.13M-20.01%4.11M13.85%5.57M27.35%5.53M28.41%5.92M71.72%18.98M35.54%5.14M74.70%4.89M
Research and development costs -38.37%10.52M-37.69%9.8M17.38%57.06M-22.75%11.01M-7.32%13.26M51.08%17.06M79.59%15.73M96.19%48.61M94.29%14.26M67.51%14.3M
Operating profit 33.43%-15.04M33.49%-14.4M-15.68%-78.19M22.02%-15.12M1.93%-18.82M-44.48%-22.6M-61.94%-21.65M-88.64%-67.59M-74.28%-19.39M-69.29%-19.19M
Net non-operating interest income expense
Other net income (expense) 22.23%3.25M39.80%3.3M164.36%11.33M59.80%3.28M103.83%3.03M315.47%2.66M2,144.76%2.36M1,337.92%4.29M3,209.68%2.05M7,731.58%1.49M
Other non- operating income (expenses) 22.23%3.25M39.80%3.3M164.36%11.33M59.80%3.28M103.83%3.03M315.47%2.66M2,144.76%2.36M1,337.92%4.29M3,209.68%2.05M7,731.58%1.49M
Income before tax 40.85%-11.79M42.44%-11.11M-5.61%-66.86M31.71%-11.84M10.82%-15.79M-32.92%-19.94M-45.45%-19.29M-78.17%-63.31M-56.71%-17.34M-56.42%-17.7M
Income tax
Net income 40.85%-11.79M42.44%-11.11M-5.61%-66.86M31.71%-11.84M10.82%-15.79M-32.92%-19.94M-45.45%-19.29M-78.17%-63.31M-56.71%-17.34M-56.42%-17.7M
Net income continuous Operations 40.85%-11.79M42.44%-11.11M-5.61%-66.86M31.71%-11.84M10.82%-15.79M-32.92%-19.94M-45.45%-19.29M-78.17%-63.31M-56.71%-17.34M-56.42%-17.7M
Minority interest income
Net income attributable to the parent company 40.85%-11.79M42.44%-11.11M-5.61%-66.86M31.71%-11.84M10.82%-15.79M-32.92%-19.94M-45.45%-19.29M-78.17%-63.31M-56.71%-17.34M-56.42%-17.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 40.85%-11.79M42.44%-11.11M-5.61%-66.86M31.71%-11.84M10.82%-15.79M-32.92%-19.94M-45.45%-19.29M-78.17%-63.31M-56.71%-17.34M-56.42%-17.7M
Basic earnings per share 41.67%-0.2142.86%-0.2-4.39%-1.1932.26%-0.2112.50%-0.28-33.33%-0.36-45.83%-0.35-48.05%-1.14-55.00%-0.31-52.38%-0.32
Diluted earnings per share 41.67%-0.2142.86%-0.2-4.39%-1.1932.26%-0.2112.50%-0.28-33.33%-0.36-45.83%-0.35-48.05%-1.14-55.00%-0.31-52.38%-0.32
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data